Lilly is committed to making life better for people living with diabetes and obesity through developing medicines that change the way healthcare providers can treat these diseases. The development and approvals of Mounjaro and Zepbound demonstrate our continued commitment to this mission. We are guided every day by our founder Colonel Eli Lilly's saying when, over a hundred years ago, he affixed his signature as the logo to our medicines: "If it bears a red Lilly, it's right."